Affiliations: Faculty of Pharmacy, Universidad de Concepcion,
Concepcion, Chile | College of Pharmacy, The University of Arizona,
Tucson, Arizona, USA
Note: [] Corresponding author: Lorenzo A. Villa, Pharm.D.,
The University of Arizona, 1295 North Martin Avenue, Tucson, AZ 85721, USA.
E-mail: [email protected]
Abstract: The scarcity of resources within both industrialized and developing
nations has catalyzed the adoption of more formalized approaches to support
decisionmaking, particularly within healthcare. In many instances, however, the
unique aspects present within developing countries may not permit the direct
translation of pharmacoeconomic guidelines or recommendations from high-income
economies. The purpose of this paper is to delineate the key attributes that
differentiate pharmacoeconomics within developing nations, including the
potential barriers to implementation and policy considerations involved.
Through its approach to comprehensively assess costs and outcomes of
technologies, pharmacoeconomic methodologies may help foster the optimal
allocation of resources to improve the effectiveness, efficiency, and equity of
healthcare delivery for societies worldwide.
